IT1151722B - L'uso di 5-0-micaminosil tlonolide nel controllo di infezini da ureaplasma - Google Patents

L'uso di 5-0-micaminosil tlonolide nel controllo di infezini da ureaplasma

Info

Publication number
IT1151722B
IT1151722B IT20816/82A IT2081682A IT1151722B IT 1151722 B IT1151722 B IT 1151722B IT 20816/82 A IT20816/82 A IT 20816/82A IT 2081682 A IT2081682 A IT 2081682A IT 1151722 B IT1151722 B IT 1151722B
Authority
IT
Italy
Prior art keywords
tlonolide
micaminosil
ureaplasma
infections
control
Prior art date
Application number
IT20816/82A
Other languages
English (en)
Other versions
IT8220816A0 (it
Inventor
Earl Eugene Ose
Herbert Andrew Kirst
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8220816A0 publication Critical patent/IT8220816A0/it
Application granted granted Critical
Publication of IT1151722B publication Critical patent/IT1151722B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/54Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IT20816/82A 1981-04-20 1982-04-19 L'uso di 5-0-micaminosil tlonolide nel controllo di infezini da ureaplasma IT1151722B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/255,575 US4341770A (en) 1981-04-20 1981-04-20 Method of controlling ureaplasma infections

Publications (2)

Publication Number Publication Date
IT8220816A0 IT8220816A0 (it) 1982-04-19
IT1151722B true IT1151722B (it) 1986-12-24

Family

ID=22968923

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20816/82A IT1151722B (it) 1981-04-20 1982-04-19 L'uso di 5-0-micaminosil tlonolide nel controllo di infezini da ureaplasma

Country Status (8)

Country Link
US (1) US4341770A (it)
JP (1) JPS57181015A (it)
AU (1) AU551044B2 (it)
IE (1) IE53106B1 (it)
IL (1) IL65522A0 (it)
IT (1) IT1151722B (it)
NZ (1) NZ200341A (it)
PH (1) PH17768A (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
US4459290A (en) * 1982-07-19 1984-07-10 Eli Lilly And Company C-23-Modified derivatives of OMT, pharmaceutical compositions and method of use
US4594337A (en) * 1983-03-03 1986-06-10 Eli Lilly And Company Methods of controlling mycoplasma infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (it) * 1964-08-05
US3769273A (en) * 1971-10-20 1973-10-30 Lilly Co Eli Bis-urea adducts of macrolide antibiotics
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
US4234690A (en) * 1979-07-16 1980-11-18 Schering Corporation Method for producing rosaramicin (rosamicin)

Also Published As

Publication number Publication date
IE820914L (en) 1982-10-20
JPS57181015A (en) 1982-11-08
IL65522A0 (en) 1982-07-30
PH17768A (en) 1984-12-06
NZ200341A (en) 1985-08-16
AU8282082A (en) 1982-10-28
IE53106B1 (en) 1988-06-22
AU551044B2 (en) 1986-04-17
IT8220816A0 (it) 1982-04-19
US4341770A (en) 1982-07-27

Similar Documents

Publication Publication Date Title
BR8108259A (pt) Microscopio de operacao
NO823019L (no) Sjampo
FI821013A0 (fi) Kompositioner
IT1153018B (it) Blocco o pannello da costruzione perfezionato
TR21767A (tr) N-fenilsulfonil-n'-pirimidinil-ve-triazinilureler
IT1155438B (it) Uso di peptidi come medicamenti
DK565181A (da) Besproejtningsapparat
DK345682A (da) Pharmaceutiske expienser
IT1158049B (it) Cefalosporine-betaine di isochinolinio
DK152219C (da) Azopigmentpraeparater
FR2507925B1 (fr) Broyeur pulverisateur
IT1151723B (it) Uso di antibiotici macrolidi nel controllo di infezioni da pasteurella
IT1190941B (it) Valvola di comando
IT1151722B (it) L'uso di 5-0-micaminosil tlonolide nel controllo di infezini da ureaplasma
DK577582A (da) Flydende deodorant
SE8101863L (sv) "archimedesskruv"
IT1151724B (it) Uso di 5-0-micaminosil tilonolide nel controllo di infezioni da pasteurella
ES263696Y (es) "disposicion de fiador".
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
BR8201041A (pt) Recalcadora de via ferrea
DE69130639D1 (de) Einzel-flüssigkeit zusammensetzung
ATA271382A (de) Verstellbare buehnenanlage
AT376569B (de) Spritzgeraet
ATA34081A (de) Tafelschere